Weight Management in Pregnancy and CVD Risk; Impact of Statins Plus Ezetimibe Post-MI; PARTNER-3 Study 5-year Results
In this week’s View, Dr. Eagle examines weight management in pregnancy related to cardiovascular disease (CVD) risk. He then considers how the addition of early ezetimibe to statin could reduce CVD after myocardial infarction (MI). Finally, Dr. Eagle explores the PARTNER-3 study results which compare transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) and the echocardiographic outcomes at five years.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Dyslipidemia, Noninvasive Imaging, Valvular Heart Disease, Lipid Metabolism, Nonstatins, Statins, Echocardiography/Ultrasound, Cardiac Surgery, Invasive Cardiovascular Angiography and Intervention, Prevention, Vascular Medicine
Keywords: Pregnancy Outcome, Pregnancy, Diabetes, Gestational, Adiposity, Maternal Health, Obesity, Myocardial Infarction, Registries, Cholesterol, LDL, Ezetimibe, Aortic Valve Stenosis, Hemodynamics, Echocardiography
